Introducing CarestationTM Insights

A cutting-edge suite of cloud-based applications, it gathers data from anaesthesia devices to identify unseen patterns.

VIEW THE VIDEO

Overview

“We honestly weren’t expecting to learn anything new around our practice from these apps. 

However, the data was incredibly eye-opening. We’ve been sincerely trying to get as good as we can, but we’ve lacked real measurement of how we’re performing. Carestation Insights is giving us the actionable data we need.”

Dr. Richard French, Christchurch Hospital University New Zealand


Carestation Insights is a suite of analytics apps powered by the fully digital Aisys CS² anaesthesia delivery system. Aisys CS² sends over 300 data points to the cloud including measured and set ventilation and gas values, alarms, machine status and error codes. 

Carestation Insights provides you with a powerful, robust and simple to use suite of cloud-based applications, easily accessed on your computer or tablet. There is enormous potential in exploring new ways of analyzing this data in order to develop a detailed and deep understanding of patient and processes through actionable clinical, operational and economic insights.


Carestation Insights is designed to support:


 

   Low flow Dashboard

Provide transparency to anesthetic agent usage and costs across your department and use the data to support low-flow initiatives.

   Checkout Dashboard

Keep track of when anesthesia machines were checked out across your entire department to improve scheduling workflow and ensure patient safety.

View the low flow Dashboard Flyer for anaesthesia department
View the low flow Dashboard Flyer for administration

View the Checkout Dashboard Flyer

Case study

Carestation™ Insights Case study

In 2016, GE teamed up with Prof. Dr. Ross Kennedy, Anesthesiologist at Christchurch Hospital, New Zealand, and Associate Professor at University of Otago, New Zealand, and Dr. Richard French, Anesthesiologist and Clinical Director at Christchurch Hospital, to use the Carestation Insights platform and its Agent Cost Dashboard to discover previously unidentified opportunities during the induction period to further reduce an already low mean fresh gas flow rate at their facility. Already low mean fresh gas flow rates during agent delivery were decreased by an additional 13% to an astounding 0.745 l/min after the intervention1

Prof. Dr. Ross Kennedy Dr. Richard French Read the case study here.


1. The role of the induction period in determining overall gas and vapour consumption. Ross Kennedy, MB ChB PhD FANZCA, Richard French2 MB BS FANZCA, Christchurch Hospital & University of Otago Christchurch, NEW ZEALAND. James Hanrahan BS MBA, and Guy Vesto BSc, GE HealthCare, Madison WI, USA


Related

Disclaimer

1. Carestation Insights is not a medical device.

2. Aisys CS2 11.x and Et Control are not available in all markets. Not cleared or approved by the USA FDA. Not for sale in the United States.